Left ventricular deformation and tissue characteristics in hypertrophic cardiomyopathy patients with HFpEF: a CMR

Jian Liu1, Zhengkai Zhao1, Qiuyi Cai1

  • 1Department of Radiology, The Third People's Hospital of Chengdu, Chengdu, 610000, China.

BMC Medical Imaging
|December 8, 2025
PubMed

Insights

Patients with hypertrophic cardiomyopathy and heart failure with preserved ejection fraction show impaired left ventricular strain and fibrosis. Cardiac magnetic resonance imaging helps identify these changes and predict heart failure status.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Biomedical Engineering

Background:

  • Hypertrophic cardiomyopathy (HCM) can lead to heart failure with preserved ejection fraction (HFpEF).
  • Assessing left ventricular (LV) function and myocardial tissue characteristics is crucial for managing HCM patients with HFpEF.

Purpose of the Study:

  • To evaluate LV deformation and tissue characteristics using cardiac magnetic resonance (CMR) in HCM patients with and without HFpEF.
  • To examine the associations between CMR parameters and heart failure status.
  • To explore correlations between CMR parameters and the H₂FPEF score.

Main Methods:

  • Retrospective analysis of 105 HCM patients undergoing 3.0-T CMR.
  • Classification into HFpEF (n=46) and non-HF (n=59) groups based on the 2019 ESC HFA-PEFF algorithm.
  • Derivation of LV strain (GRS, GCS, GLS) and strain rates using CMR feature tracking.
  • Myocardial tissue characterization including native T1/T2 mapping, extracellular volume fraction (ECV), and late gadolinium enhancement (LGE).

Main Results:

  • HCM patients with HFpEF exhibited reduced LV systolic and early-diastolic strain rates (sGRSr, sGCSr, sGLSr, eGLSr) compared to non-HF patients.
  • The HFpEF group showed higher prevalence/extent of LGE and elevated native T1 and ECV values.
  • Lower LV-eGLSr and higher segmental ECV were independent predictors of HFpEF, alongside atrial fibrillation and drinking.
  • The H₂FPEF score correlated significantly with native T1, ECV, and T2 values.

Conclusions:

  • HCM patients with HFpEF display systolic and diastolic dysfunction with increased myocardial fibrosis.
  • CMR-derived strain (LV-eGLSr) and tissue characterization (ECV) are independent predictors of HFpEF in HCM.
  • CMR parameters, including strain and tissue characteristics, complement the H₂FPEF score for early detection and risk stratification of HFpEF in HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
685
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
431
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
196
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
447